Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact

The Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact (AMPLI-PPHI) project funded by UNITAID developed a business case for tranexamic acid, misoprostol, and heat-stable carbetocin. This business case provides an overall picture of the current market landscape for these three drugs and highlights barriers and opportunities for expanded access to quality-assured products.